ArticleFrontiers in medicine2026

Three-year sublingual immunotherapy for HDM-induced allergic rhinoconjunctivitis: sustained ocular symptom improvement.

Chenggang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.